Selection of these three PCOS women was based upon their previously determined stem cell characteristics of enhanced lipid accumulation during adipogenesis in vitro [25] with PPARγ and CEBPα overexpression (Additional file 1: Supplemental Fig. 1). The gene discussed is CEBPA; the disease is polycystic ovary syndrome.